The UFC is looking to get involved with research into psychedelic drugs as a therapy for fighters’ brain health. The promotion has been in contact with Johns Hopkins University about its psychedelics…
A couple of doses of a psychedelic drug may treat depression as well as one of the most commonly prescribed antidepressants, a small and short study published Wednesday shows. A Phase 2 clinical…
Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the…
Chronic stress and depression are known to reduce the number of nerve connections in the prefrontal cortex of the brain. Drugs with rapid antidepressant effects, including ketamine and classic psychedelics such as…
An extraordinary new study from a team of scientists at Yale University is reporting the first direct cellular demonstration of a single psilocybin dose inducing neural plasticity in a mammalian brain. The…
In a new study, a group of researchers led by Prof. Dr. Gerhard Gründer wants to gain robust findings on the efficacy and safety of psilocybin in the treatment of treatment-resistant major depression. Psilocybin as…
A groundbreaking British study has found that the psychedelic drug psilocybin can be safely given to patients, and may be used to treat a range of mental health conditions. Recreational use of…
Objectives of this learning scenario, developed by NYU Langone’s High School Bioethics Project, are to understand post-traumatic stress disorder (PTSD) and the symptoms it causes, learn how the chemical psilocybin, found in…
An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and…